¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-25
±³À°ÀÏÀÚ : 2020-07-25
±³À°Àå¼Ò : ¿ÀÇÁ¶óÀÎ & ¿Â¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B)  
±³À°ÁÖÁ¦ : Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)
ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ  
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070  
À̸ÞÀÏ : office@intervention.or.kr      
±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í ¿Â¶óÀÎ »çÀüµî·Ï 10000¿ø / ¿ÀÇÁ¶óÀÎ-»çÀüµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø / ¿ÀÇÁ¶óÀÎ-ÇöÀåµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:00~08:10 Predisposing factors for the iliac limb migration after EVAR  ±èÇü¿í(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:10~08:20 Real world Outcome of the Paclitaxel-Eluting Stents for TASC C and D Femoropoliteal Lesions  ±Ç·Á¹Î(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:20~08:30 Safety and Efficacy of Mynx Vascular Closure Device for the Closure of Common Femoral Artery Access Site in a Situation of Ipsilateral Stent Placement  ÀåÇý¹Î(°Ç±¹ÀǾÖ) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:30~08:40 Percutaneous Intervention for Salvage of Non-Maturing Arteriovenous Fistulas: Which is the Better Approach, Arterial or Venous?  ÀÌ»ó¹Î(°æ»óÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:40~08:50 Usefulness and Feasibility of Clinch Knot with a Guidewire in Place for Temporary Hemostasis in Arteriovenous Dialysis Access Intervention  ¹Ú¼ºÁØ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:50~09:00 Radiologically Guided Placement of Central Venous Ports: Retrospective Analysis of the Clinical Outcome and Associated Risk Factors in 2883 Port Placements at a Single Center  Á¤»óÈÆ(Â÷ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:00~09:50 ÀÎÅͺ¥¼Ç °ü·Ã ÀÇ·áºÐÀïÀÇ ¿¹½Ã¿Í ´ëó¹æ¾È  ÀÌ°æ±Ç(¹ý¹«¹ýÀÎ ¿¤ÄÉÀÌÆÄÆ®³Ê½º) 
È޽Ġ07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:50~10:10 Coffee Break  () 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:10~10:40 ÀÎÅͺ¥¼Ç°ú ¸ù°ñÀǻ砠±èÀ±È¯(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:40~11:00 Treatment of complex vascular malformation  ±è°æ·¡(UNC USA) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:00~11:20 Budd-Chiari Syndrome: East vs. West  Penguin-xu Ding(First Affiliated Hospital of Zhengzhou University China) 
±âŸ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:20~12:00 ÃÑȸ  () 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 12:00~12:40 Experience using the Angio-CT system for Prostate artery embolization  Á¤ÇýµÎ(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ) 
È޽Ġ07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 12:40~13:00 Coffee Break  () 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:00~13:10 The Value of Pre-procedural Magnetic Resonance Imaging in Genicular Artery Embolization for Patients with Osteoarthritic Knee Pain  ÃÖÁø¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:10~13:20 Embolization using a new quickly soluble gelatin sponge particle to treat chronic pain in musculoskeletal disorders  ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:20~13:30 Therapeutic outcomes of embolotherapy of extremity bone arteriovenous malformation with ethanol, coils, and n-butyl cyanoacrylate  ±è¶õ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:30~13:40 Embolosurgery of a localized extracranial arteriovenous malformation: Analysis of angiographic type, embolization technique, and outcome  Â÷Áß±Ù(°æºÏÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:40~13:50 Efficacy and safety of transcatheter arterial embolization for active arterial esophageal bleeding: a single- center experience  Alrashidi Ibrahim(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:50~14:00 Does nonvascularized lymph node transplantation facilitates the lymphangiogenesis?  ±è°Ç¿µ(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:00~14:15 Large HCC : How/why I do DEB-TACE  ¿ÀÁ¤¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:15~14:30 Large HCC : How/why I do cTACE  ±èȿö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:30~14:45 Large HCC : How/why I do Y-90  ±è°æ¹Î(¿¬¼¼ÀÇ´ë) 
Åä·Ð 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:45~14:55 Discussion  ¼­Å¼® À̺´Âù(°í·ÁÀÇ´ë Àü³²ÀÇ´ë) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:55~15:10 Prostatic artery embolization  Á¤ÇýµÎ(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:10~15:25 Musculoskeletal embolization  ÀÌ»óȯ(¾çÁöº´¿ø) 
±³À°½Ã°£ 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:25~15:40 AVF  ±Ç¿äÇÑ(¾ÆÁÖÀÇ´ë) 
Åä·Ð 07-25 °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:40~15:50 Discussion  ¼º³«Á¾ Àüâȣ(¼­¿ïº½¿µ»óÀÇÇаú ºÎ»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2020 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö (¿Â¶óÀÎ.¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-25
´ÙÀ½±Û ¿Â¶óÀÎ Á¦28Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ (¿Â¶óÀÎ) : 2020-07-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 6 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 10 2024-05-27
20878 ¼­¿ï 2024³â ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ Á¦3ȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 6 2024-05-27
20877 ¼­¿ï °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ILD School 202 : 2024-06-29 0 5 2024-05-27
20876 ¼­¿ï 2024 ´ëÇѼö¼ú°¨¿°ÇÐȸ Çмú´ëȸ : 2024-06-29 0 8 2024-05-27
20875 ¼­¿ï ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28 0 4 2024-05-27
20874 ¼­¿ï 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28 0 14 2024-05-27
20873 °æ±â 2024³â Á¦ 2ȸ ÆÄÁֽà ÀÇ»çȸ ÃÑȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 4 2024-05-27
20872 ¼­¿ï (¿Â¶óÀÎ) Á¦95ȸ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2024-06-28 0 13 2024-05-27
20871 ¼­¿ï (¿Â¶óÀÎ) Á¦95ȸ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2024-06-28 0 13 2024-05-27
20870 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-28 0 8 2024-05-27
20869 ¼­¿ï ´ëÇѹýÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-28 0 5 2024-05-27
20868 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 6 2024-05-27
20867 ¼­¿ï ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 1 : 2024-06-27 0 5 2024-05-27
20866 °æ±â ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Áö¿ª»çȸ Á¤½Å°Ç°­ ÁõÁøÀ» À§ÇÑ Ä¡·áÀû Á¢±Ù : 2024-06-26 0 10 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷